0001209191-17-012752.txt : 20170221
0001209191-17-012752.hdr.sgml : 20170221
20170221164642
ACCESSION NUMBER: 0001209191-17-012752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170216
FILED AS OF DATE: 20170221
DATE AS OF CHANGE: 20170221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keuer Thomas A
CENTRAL INDEX KEY: 0001290482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 17625657
MAIL ADDRESS:
STREET 1: C/O ARCA BIOPHARMA, INC.
STREET 2: 11080 CIRCLEPOINT RD, STE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-16
0
0000907654
ARCA biopharma, Inc.
ABIO
0001290482
Keuer Thomas A
11080 CIRCLEPOINT ROAD
SUITE 140
WESTMINSTER
CO
80020
0
1
0
0
Chief Operating Officer
Common Stock
14900
D
Stock Option (right to buy)
2.50
2017-02-16
4
A
0
25200
0.00
A
2027-02-15
Common Stock
25200
25200
D
Includes (i) remaining 2,443 previously reported shares issued as Restricted Stock Units ("RSUs") under the 2013 Amended and Restated Equity Incentive Plan (the "Plan") that vest in two equal annual installments beginning on 2/27/17, and (ii) 2,414 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 10,043 previously reported shares of common stock owned.
Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
/s/ Thomas A. Keuer
2017-02-21